Eye-movement testing in people with early Parkinson’s
Part of Brain & nervous system, Mental health clinical trials.
This study uses video recordings of your eye movements to learn more about Parkinson’s disease. It may help researchers better tell Parkinson’s apart from other movement conditions and understand how the disease affects the brain early on.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a clinical diagnosis of Parkinson’s disease (idiopathic)
- You had a brain MRI within the last 12 months as part of routine care
- You previously had a DaTSCAN or a PET scan with F-DOPA that confirms dopamine nerve changes
- Your Parkinson’s severity is early (Hoehn & Yahr stage 1 to 3)
- Your eye movement exam is normal or only slightly off for smooth tracking
- You can do the study in French and have a caregiver who can support you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with Parkinson’s adapt their movements and how their brain sensorimotor system works. It may help researchers improve understanding of Parkinson’s and refine movement-focused therapies.
This study tests whether a special eye-tracking camera can help diagnose the cause of white matter hypersignals—unusual bright spots seen on brain MRI. Researchers want to see if eye movements can reveal clues about what's causing these brain changes.
This study uses a simple eye movement test to see if it can help tell the difference between Parkinson's disease, Essential tremor, and healthy people. The goal is to find a better way to diagnose and track these conditions.
This study uses a special eye camera to see if early signs of Parkinson's and similar movement disorders can be spotted in the retina. It may help doctors diagnose these conditions sooner and more easily.
This study looks at how the brain's dopamine system works in people with Parkinson's disease by measuring signals from the eyes. It may help find a simple way to track the disease, which could lead to better care.
This study looks at how people with Alzheimer's disease move their eyes compared to healthy people. The goal is to develop simple, non-invasive eye-tracking tests that could help diagnose Alzheimer's disease earlier and more accurately.
Hear when a new Parkinson Disease, Idiopathic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.